Matches in SemOpenAlex for { <https://semopenalex.org/work/W2060955703> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W2060955703 endingPage "S40" @default.
- W2060955703 startingPage "S40" @default.
- W2060955703 abstract "The objectives of this study were to develop transplantation regimens for patients with advanced myelodysplastic syndrome (MDS) that would be associated with low transplantation-related mortality and improved relapse-free survival. Sixty patients with advanced MDS or acute myeloid leukemia evolving from MDS (sAML), 12 to 62 years old (median, 40 years), were conditioned with busulfan (7 mg/kg) and TBI (6 x 200 cGy) (BU/TBI) and received transplants from related (n = 20) or unrelated donors (n = 40). By French-American-British (FAB) criteria, 21 patients had refractory anemia with excess blasts (RAEB), 16 had RAEB in transformation (RAEB-T), 15 had sAML, and 8 had chronic myelomonocytic leukemia (CMML). By International Prognostic Scoring System (IPSS) criteria, 1 patient had low, 10 had intermediate-1, 13 had intermediate-2, and 31 had high-risk MDS (5 patients had proliferative CMML). All evaluable patients achieved sustained engraftment. The cumulative incidence (CI) of acute GVHD grades II to IV was 83% with unrelated donors and 85% with related donors. The CI of relapse was 25% at 3 years. The incidence of nonrelapse mortality (NRM) at 100 days was 38%. The Kaplan-Meier estimate of survival was 26% at 3 years. Major causes of death were relapse, organ failure, GVHD, and infection. In multivariate analysis, improved relapse-free survival was associated with good cytogenetic risk (P = .002) and shorter disease duration (P = .004). NRM was increased with longer disease duration (P = .0002), positive cytomegalovirus serology (P = .02), and male sex (P = .02). Relapse was associated with poor cytogenetic risk (P = .0004). Thus, BU/TBI conditioning as used in this trial was associated with relapse rates comparable to those observed with a previously used more intensive regimen combining BU/TBI with cyclophosphamide. However, despite the omission of cyclophosphamide, transplantation-related morbidity and mortality were considerable, particularly with transplants from unrelated donors. Future trials should explore the efficacy and tolerability of reduced-intensity conditioning regimens.Biol Blood Marrow Transplant 2002;8(3):161-9." @default.
- W2060955703 created "2016-06-24" @default.
- W2060955703 creator A5006871789 @default.
- W2060955703 creator A5022490857 @default.
- W2060955703 creator A5023971906 @default.
- W2060955703 creator A5024127853 @default.
- W2060955703 creator A5024960041 @default.
- W2060955703 creator A5025768647 @default.
- W2060955703 creator A5041806045 @default.
- W2060955703 creator A5048068750 @default.
- W2060955703 creator A5068540445 @default.
- W2060955703 creator A5089265184 @default.
- W2060955703 date "2005-01-01" @default.
- W2060955703 modified "2023-09-25" @default.
- W2060955703 title "P-43 Effect of the treatment withCA2 anti-TNF monoclonal antibody on the bone marrow (BM) progenitor cell reserve and function and stromal cell function in patients with myelodysplastic syndrome (MDS). A study of the Greek mds study group" @default.
- W2060955703 doi "https://doi.org/10.1016/s0145-2126(05)80107-9" @default.
- W2060955703 hasPublicationYear "2005" @default.
- W2060955703 type Work @default.
- W2060955703 sameAs 2060955703 @default.
- W2060955703 citedByCount "0" @default.
- W2060955703 crossrefType "journal-article" @default.
- W2060955703 hasAuthorship W2060955703A5006871789 @default.
- W2060955703 hasAuthorship W2060955703A5022490857 @default.
- W2060955703 hasAuthorship W2060955703A5023971906 @default.
- W2060955703 hasAuthorship W2060955703A5024127853 @default.
- W2060955703 hasAuthorship W2060955703A5024960041 @default.
- W2060955703 hasAuthorship W2060955703A5025768647 @default.
- W2060955703 hasAuthorship W2060955703A5041806045 @default.
- W2060955703 hasAuthorship W2060955703A5048068750 @default.
- W2060955703 hasAuthorship W2060955703A5068540445 @default.
- W2060955703 hasAuthorship W2060955703A5089265184 @default.
- W2060955703 hasConcept C126322002 @default.
- W2060955703 hasConcept C143998085 @default.
- W2060955703 hasConcept C144301174 @default.
- W2060955703 hasConcept C2777408962 @default.
- W2060955703 hasConcept C2777928532 @default.
- W2060955703 hasConcept C2780007613 @default.
- W2060955703 hasConcept C2780240888 @default.
- W2060955703 hasConcept C2780611847 @default.
- W2060955703 hasConcept C2780817109 @default.
- W2060955703 hasConcept C2911091166 @default.
- W2060955703 hasConcept C38180746 @default.
- W2060955703 hasConcept C71924100 @default.
- W2060955703 hasConcept C88879693 @default.
- W2060955703 hasConcept C90924648 @default.
- W2060955703 hasConceptScore W2060955703C126322002 @default.
- W2060955703 hasConceptScore W2060955703C143998085 @default.
- W2060955703 hasConceptScore W2060955703C144301174 @default.
- W2060955703 hasConceptScore W2060955703C2777408962 @default.
- W2060955703 hasConceptScore W2060955703C2777928532 @default.
- W2060955703 hasConceptScore W2060955703C2780007613 @default.
- W2060955703 hasConceptScore W2060955703C2780240888 @default.
- W2060955703 hasConceptScore W2060955703C2780611847 @default.
- W2060955703 hasConceptScore W2060955703C2780817109 @default.
- W2060955703 hasConceptScore W2060955703C2911091166 @default.
- W2060955703 hasConceptScore W2060955703C38180746 @default.
- W2060955703 hasConceptScore W2060955703C71924100 @default.
- W2060955703 hasConceptScore W2060955703C88879693 @default.
- W2060955703 hasConceptScore W2060955703C90924648 @default.
- W2060955703 hasLocation W20609557031 @default.
- W2060955703 hasOpenAccess W2060955703 @default.
- W2060955703 hasPrimaryLocation W20609557031 @default.
- W2060955703 hasRelatedWork W1487950379 @default.
- W2060955703 hasRelatedWork W1955322177 @default.
- W2060955703 hasRelatedWork W2055362225 @default.
- W2060955703 hasRelatedWork W2100748266 @default.
- W2060955703 hasRelatedWork W2411602174 @default.
- W2060955703 hasRelatedWork W2578670668 @default.
- W2060955703 hasRelatedWork W2752242534 @default.
- W2060955703 hasRelatedWork W3012813820 @default.
- W2060955703 hasRelatedWork W3095059406 @default.
- W2060955703 hasRelatedWork W4243847632 @default.
- W2060955703 hasVolume "29" @default.
- W2060955703 isParatext "false" @default.
- W2060955703 isRetracted "false" @default.
- W2060955703 magId "2060955703" @default.
- W2060955703 workType "article" @default.